Lemierre's syndrome.
Venglarcik
John
J
Northeastern Ohio Universities, College of Medicine and Tod Children's Hospital, Youngstown, Ohio, USA.
D000038:Abscess / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D000293:Adolescent; D017677:Age Distribution; D000900:Anti-Bacterial Agents; D016470:Bacteremia / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D005674:Fusobacterium Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D005675:Fusobacterium necrophorum / Q000302:isolation & purification*; D006801:Humans; D015994:Incidence; D007601:Jugular Veins; D008297:Male; D010612:Pharyngitis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D011379:Prognosis; D018570:Risk Assessment; D013577:Syndrome; D013924:Thrombophlebitis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology
D000900:Anti-Bacterial Agents